|Videos|May 2, 2023
Interview with Jubilant’s President Chris Preti
Author(s)Jubilant
Key Learning Objectives:
- Progress on previously announced $285 million expansion plan will double capacity for sterile injectables fill/finish at Jubilant HollisterStier’s Spokane, Wash. Facility
- Strengthen’s Jubilant HollisterStier’s position in addressing contract manufacturing needs of major producers throughout North America
- Jubilant HollisterStier is a leading contract manufacturer of sterile injectables, ophthalmics, optics, sterile and non-sterile topicals and liquids
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Syngene Extends Major Research Collaboration with BMS
2
Sharp Expands European Injectable Packaging Capacity With €20 million Investment
3
State of the Bio/Pharma Workforce: A Comparative Analysis of Employment Trends and Industry Sentiment
4
The Shift from Containment to Protection: Packaging Trends Impacting Pharma
5